Italia markets closed

BMY Jan 2026 85.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,24000,0000 (0,00%)
Alla chiusura: 03:20PM EDT
Schermo intero
Chiusura precedente0,2400
Aperto0,3700
Denaro0,2500
Lettera0,3900
Prezzo d'esercizio85,00
Scadenza2026-01-16
Min-Max giorno0,2400 - 0,3700
Contratto - Min-MaxN/D
Volume11
Open Interest1,28k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri